Suppr超能文献

ART/IVF 中卵巢刺激不良反应者的最佳方案是什么?

What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?

机构信息

Reproductive Endocrinology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

出版信息

Front Endocrinol (Lausanne). 2020 Apr 17;11:192. doi: 10.3389/fendo.2020.00192. eCollection 2020.

Abstract

The infertile patients with aging ovaries-also sometimes referred to as impending premature ovarian insufficiency (POI), impending premature ovarian failure (POF), or poor ovarian responders (POR), constitute a significant and increasing bulk of the patients appealing to IVF/ART. Different causes have been cited in the literature, among the identified etiologies, including chromosomal and genetic etiology, metabolic, enzymatic, iatrogenic, toxic, autoimmune, and infectious causes. Although the most successful and ultimate treatment of POI/POF/POR patients is egg donation (ED), many, if not most, of these infertile women are reluctant to consent to ED upon the initial diagnostic interview, requesting alternative solutions despite the low odds for success. Despite anecdotal case reports, no unequivocal treatment proved to be successful for these patients in prospective randomized controlled trials. Nevertheless, the addition of growth hormone (GH) to ovarian stimulation in POR with GH deficiency may improve the results of controlled ovarian hyperstimulation (COH) and the IVF success. In patients with autoimmune etiology for POR/POI, the combination of glucocorticosteroids, pituitary-ovarian suppression, and COH may be successful in achieving the desired conception.

摘要

不孕伴卵巢衰老的患者 - 有时也被称为即将发生的卵巢早衰(POI)、即将发生的卵巢功能衰竭(POF)或卵巢低反应(POR),构成了大量且不断增加的寻求 IVF/ART 的患者群体。文献中提到了不同的原因,在已确定的病因中,包括染色体和遗传病因、代谢、酶、医源性、毒性、自身免疫和感染性原因。尽管 POI/POF/POR 患者最成功和最终的治疗方法是捐卵(ED),但许多(如果不是大多数)这些不孕女性在初次诊断性访谈时不愿意同意 ED,尽管成功的几率很低,但仍要求选择其他解决方案。尽管有一些轶事病例报告,但在前瞻性随机对照试验中,没有一种明确的治疗方法被证明对这些患者有效。然而,在 GH 缺乏的 POR 患者中,将生长激素(GH)添加到卵巢刺激中可能会改善控制性卵巢过度刺激(COH)和 IVF 的结果。对于 POR/POI 的自身免疫病因患者,糖皮质激素、垂体-卵巢抑制和 COH 的联合治疗可能成功实现预期妊娠。

相似文献

1
What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?
Front Endocrinol (Lausanne). 2020 Apr 17;11:192. doi: 10.3389/fendo.2020.00192. eCollection 2020.
5
Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis.
J Assist Reprod Genet. 2018 Mar;35(3):475-482. doi: 10.1007/s10815-017-1096-y. Epub 2017 Dec 5.
6
Management Strategies for POSEIDON Group 2.
Front Endocrinol (Lausanne). 2020 Feb 27;11:105. doi: 10.3389/fendo.2020.00105. eCollection 2020.
7
9
ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation.
JBRA Assist Reprod. 2018 Mar 1;22(1):52-55. doi: 10.5935/1518-0557.20180011.
10
Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve.
Reprod Biomed Online. 2020 Feb;40(2):245-253. doi: 10.1016/j.rbmo.2019.09.007. Epub 2019 Sep 19.

引用本文的文献

2
Effects of Different Gonadotropin-Releasing Hormone Agonists on IVF/ICSI-ET Outcomes in Long Protocol: A Retrospective Study.
Int J Womens Health. 2025 May 8;17:1313-1320. doi: 10.2147/IJWH.S517738. eCollection 2025.
3
Conception and Concern: A Review of Breast Cancer Risk in Assisted Reproductive Technology.
Int J Biol Sci. 2025 Mar 24;21(6):2647-2671. doi: 10.7150/ijbs.105357. eCollection 2025.
4
Novel perspectives on growth hormone regulation of ovarian function: mechanisms, formulations, and therapeutic applications.
Front Endocrinol (Lausanne). 2025 Apr 9;16:1576333. doi: 10.3389/fendo.2025.1576333. eCollection 2025.
5
Identification of a novel mutation in gene associated with the germinal vesicle arrest of oocytes.
Biochem Biophys Rep. 2024 Nov 22;40:101886. doi: 10.1016/j.bbrep.2024.101886. eCollection 2024 Dec.
7
Endometrial stem cell-derived exosomes repair cisplatin-induced premature ovarian failure via Hippo signaling pathway.
Heliyon. 2024 May 21;10(10):e31639. doi: 10.1016/j.heliyon.2024.e31639. eCollection 2024 May 30.
8
The impact of ovarian stimulation on the human endometrial microenvironment.
Hum Reprod. 2024 May 2;39(5):1023-1041. doi: 10.1093/humrep/deae048.
9
Cai's prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders.
J Ovarian Res. 2024 Feb 14;17(1):40. doi: 10.1186/s13048-024-01363-x.

本文引用的文献

3
Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve.
Reprod Biomed Online. 2020 Feb;40(2):245-253. doi: 10.1016/j.rbmo.2019.09.007. Epub 2019 Sep 19.
4
The effects of acupuncture on pregnancy outcomes of in vitro fertilization: a systematic review and meta-analysis.
BMC Complement Altern Med. 2019 Jun 14;19(1):131. doi: 10.1186/s12906-019-2523-7.
5
An Observational Retrospective Cohort Trial on 4,828 IVF Cycles Evaluating Different Low Prognosis Patients Following the POSEIDON Criteria.
Front Endocrinol (Lausanne). 2019 May 8;10:282. doi: 10.3389/fendo.2019.00282. eCollection 2019.
6
Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification.
Front Endocrinol (Lausanne). 2019 May 8;10:281. doi: 10.3389/fendo.2019.00281. eCollection 2019.
7
Androgens and ovarian function: translation from basic discovery research to clinical impact.
J Endocrinol. 2019 Aug;242(2):R23-R50. doi: 10.1530/JOE-19-0096.
8
Cumulative live birth rates in low-prognosis women.
Hum Reprod. 2019 Jun 4;34(6):1030-1041. doi: 10.1093/humrep/dez051.
9
Do poor-responder patients undergoing IVF benefit from splitting and increasing the daily gonadotropin dose?
Gynecol Endocrinol. 2019 Oct;35(10):890-893. doi: 10.1080/09513590.2019.1608520. Epub 2019 Apr 29.
10
Physiological and Pathological Androgen Actions in the Ovary.
Endocrinology. 2019 May 1;160(5):1166-1174. doi: 10.1210/en.2019-00101.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验